WELCOME TO JOHNS HOPKINS HEALTH ALERTS!

This free public service from Johns Hopkins Medicine helps keep you up to date on the latest breakthroughs for the most common medical conditions which prevent healthy aging. Browse all the articles via the Health Alert Topics navigation bar on the right, or read the headlines below.


Get the latest news sent straight to your Inbox. Register now for your FREE Johns Hopkins Health Alerts. Check the boxes below for all the topics you are interested in, enter your email address, and click "Send." It's fast, easy, and FREE.   Benefits of Being A Registered User

Enter your email here: (Example: yourname@domain.com)
Please send my alerts as:

We value your privacy and will never rent your email address.Already a Member? Manage your Health Alerts


Johns Hopkins Health Alert

Urine-Based Prostate Cancer Screening Test Looks Promising

Comments (1)

Today the diagnosis of prostate cancer typically begins with an abnormal prostate-specific antigen (PSA) test or perhaps a worrisome finding on a digital rectal exam (DRE). But because an elevated PSA level can be caused by benign prostatic hyperplasia (BPH), prostatitis, as well as prostate cancer, there is a need for a more specific screening test. Now a report in the journal Cancer Research (Volume 68, page 646) suggests that a urine-based prostate cancer test may be the answer.

An experimental prostate cancer screening test that is performed on a urine sample may be more reliable than the traditional PSA test. In a recent study, researchers evaluated a group of biomarkers found in urine for their ability to detect prostate cancer. (A biomarker is a substance found in the blood or other body fluids or tissues that can be used to detect or monitor a disease or to determine the effects of treatment.)

The researchers examined seven biomarkers in urine samples from men scheduled for a prostate biopsy or radical prostatectomy. Then they correlated the results of the procedures with the presence of the various biomarkers.

 

Used together, four of the substances -- GOLPH2, SPINK1, PCA3, and TMPRSS2:ERG -- identified which men had cancer. The group of four biomarkers outperformed PSA testing in its ability to specifically identify prostate cancer.

 

The main problem with PSA testing is that an elevated PSA level may also be caused by benign prostatic hyperplasia or prostatitis. This lack of specificity in PSA testing often leads to unnecessary biopsies. Although early findings are promising, more research is needed to improve the performance of urine tests for prostate cancer. For now, doctors will continue to rely on the current PSA test.

Posted in Prostate Disorders on September 24, 2009
Reviewed February 2011


Medical Disclaimer: This information is not intended to substitute for the advice of a physician. Click here for additional information: Johns Hopkins Health Alerts Disclaimer


Notify Me

Would you like us to inform you when we post new Prostate Disorders Health Alerts?

Post a Comment

Comments

Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.

The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or Remedy Health Media, LLC, which has no responsibility for any comments posted on this site.


Why with my PSA in the 20's for years, and I have been told by two urologists that I probably have a slight continuing prostate(large) infection,(yes, I have had a bad prostatitus attack and have had 4 biopsy, no cancer), why is there no medication to clear up this possible infection ?

Posted by: stasch | September 26, 2009 2:28 PM

Post a Comment


Already a subscriber?

Login

Forgot your password?

New to Johns Hopkins Health Alerts?

Register to submit your comments.

(example: yourname@domain.com)

(800) 829-0422

Registered Users Log-in:

Forgot Password?

Become a Registered User!
It's fast and FREE!
The Benefits of Being a Registered User

Health Topic Pages

  • Health Alert
  • Special Report

What is this?

XML


Johns Hopkins' Bestsellers Prostate Disorders

Our Featured Titles:

Johns Hopkins Prostate Disorders White Paper

The Johns Hopkins Prostate Bulletin Cover

  • The Johns Hopkins Prostate Disorders Bulletin
    The Johns Hopkins Prostate Disorders Bulletin is a quarterly publication that presents the latest treatment information available on prostate cancer, enlarged prostate (BPH), and prostatitis to help you take charge of your medical care for prostate disease. Each issue is like having an in-depth consultation with a leading specialist. PLUS, subscribe now and get a special discount PLUS 5 FREE Special Reports as INSTANT PDF DOWNLOADS:
    • Special Report #1: BPH (Benign Prostatic Hyperplasia)
    • Special Report #2: Diet and Prostate Health
    • Special Report #3: Treating Overactive Bladder
    • Special Report #4: Chronic Prostatitis: New Research, Renewed Hope
    • Special Report #5: The Radical Prostatectomy

    Click here to read more or order The Johns Hopkins Prostate Disorders Bulletin.


    Related Titles:

    THE JOHNS HOPKINS PROSTATE LIBRARY


    A series of cutting-edge publications designed to address your specific prostate questions.

    • Choosing the Right Treatment for Prostae Cancer
      A must-read primer for any man recently diagnosed with prostate cancer who is looking for answers to pressing questions about treatment options. Our specialists explain in-depth: proactive surveillance, also known as expectant management ... nerve-sparing radical prostatectomy . . . radiation therapy, including EBRT, 3DCRT, IMRT, IGT, and brachytherapy. Written by Jacek L. Mostwin M.D. and colleagues at the world-renowned James Buchanan Brady Urological Institute at Johns Hopkins - the hospital and urology center ranked #1 year after year by U.S. News & World Report -- Choosing the Right Treatment for Prostate Cancer takes you step-by-step through the decision-making process to help you make informed choices.
      Read More

    Restoring Sexual Intimacy After Prostate Cancer Treatment

    The Best Treatment Strategies for BPH

    • The Best Treatment Strategies for BPH
      Written by a team of top specialists at Johns Hopkins' renowned Brady Urological Institute, this essential guide presents the latest thinking on managing benign prostatic hyperplasia (BPH) or enlarged prostate. The report answers dozens of questions from patients searching for practical, no-nonsense advice on living with BPH. It provides a thorough discussion of your surgical options when medication no longer works, weighing the pros and cons of TUNA, TUMT, and TURP. Armed with the information in this guide, you'll be able to meet with your own physician and make the right decisions in your quest for the best possible outcome.
      Read more...

    The Latest Treatments for Advanced Prostate Cancer

    • The Latest Treatments for Advanced Prostate Cancer
      If you've just received the bad news that your prostate cancer has returned, America's #1 Urology Center's specialists offer this up-to-the-minute treatment guide is designed as a detailed primer on advanced prostate cancer, so you can know all your options for dealing with this major health
      Read more...